EMEA (Europe, Middle East and Africa) Radiopharmaceuticals in Nuclear Medicine Market Report 2017

-
EMEA (Europe, Middle East and Africa) Radiopharmaceuticals in Nuclear Medicine Market Report 2017

EMEA (Europe, Middle East and Africa) Radiopharmaceuticals in Nuclear Medicine Market Report 2017
In this report, the EMEA Radiopharmaceuticals in Nuclear Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Radiopharmaceuticals in Nuclear Medicine market competition by top manufacturers/players, with Radiopharmaceuticals in Nuclear Medicine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for each application, including
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
If you have any special requirements, please let us know and we will offer you the report as you want.

Comments

Post a Comment

Popular posts from this blog

Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices

-
Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices For Brief Details Visit Our Site  www.reportsandmarkets.com Now, Chinese regulations on medical devices are undergoing earthshaking changes. China’s new leaders have recognized that the regulations for supervision and administration of medical devices are far from perfect along with rapid economic and population growth over the pasted three decades. Chinese state council issued the latest “Regulations for the Supervision and Administration of Medical Devices” to try to completely change such imperfect status. China Food and Drug Administration issued the latest “Measures for the Administration of Medical Device Registration”, “Regulations on the Administration of the Instructions and Labels of Medical Devices”, “Measures for the Superv...
Read more

Convenience Retailing at the Service Station 2016

-
Convenience Retailing at the Service Station 2016 Convenience Retailing at the Service Station 2016 Summary This report is an essential resource for service station retailers big and small looking to increase the productivity and attractiveness of their proposition to motorists across the globe. Verdict examines the key ways to adopt a low risk, high reward convenience and foodservice offer to the forecourt through detailed market data, and insightful analysis of the trends impacting key retailers and markets over the coming five years. Key Findings The increasing demand from motorists for more variety in food and drinks combined with the growing number of shoppers looking to their local forecourt store as a food-to-go destination will put pressure on fuel retailers to develop a better foodservice proposition. Addressing the dietary needs of special consumer segments as well as those seeking healthier menu options will become a rising priority for forecourt retailers over the next yea...
Read more